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ABSTRACT
Background: Pulmonary Rehabilitation (PR) is an
important treatment for patients with chronic
obstructive pulmonary disease (COPD) but it is not
established whether any baseline parameter can predict
response or compliance.
Aim: To identify whether baseline measures can
predict who will complete the programme and who will
achieve a clinically significant benefit from a Minimum
Clinical Important Difference (MCID) in terms of
exercise capacity and health-related quality of life
(HRQoL).
Methods: Data were collected prospectively from
patients with COPD at their baseline assessment for an
outpatient PR programme in one of eight centres
across London. ‘Completion’ was defined as attending
at least 75% of the designated PR visits and return for
the follow-up evaluation. The MCID for outcome
measures was based on published data.
Results: 787 outpatients with COPD (68.1±10.5 years
old; 49.6% males) were included. Patients who
completed PR (n=449, 57.1%) were significantly older
with less severe airflow obstruction, lower anxiety and
depression scores, less dyspnoea and better HRQoL.
Only baseline CAT score (OR=0.925; 95% CI 0.879 to
0.974; p=0.003) was retained in multivariate analysis.
Patients with the lowest baseline walking distance were
most likely to achieve the MCID for exercise capacity.
No baseline variable could independently predict
achievement of an MCID in HRQoL.
Conclusions: Patients with better HRQoL are more
likely to complete PR while worse baseline exercise
performance makes the achievement of a positive
MCID in exercise capacity more likely. However, no
baseline parameter could predict who would benefit the
most in terms of HRQoL.
INTRODUCTION
Chronic obstructive pulmonary disease
(COPD) is a disorder characterised by high
morbidity and mortality.1 Pulmonary rehabili-
tation (PR) is a multidimensional, non-
pharmacological intervention that has been
established as the standard of care for the
management of this condition.2 PR pro-
grammes (which include supervised exercise
training) have been shown in clinical trials to
improve exercise capacity,3–5 reduce dys-
pnoea,6 7 anxiety and depression,8 9 while
improving quality of life7 among patients
with COPD, and these ﬁndings are sup-
ported by data from clinical practice.10–12
Drop-out rates for those who attend a PR
programme are high,2 13 with up to 50–75%
of the initial COPD population referred for
PR declining to take part or failing to com-
plete the programme.13–15 Although PR has a
compelling evidence base, some patients with
COPD do not achieve a clinically signiﬁcant
improvement.16 Maximising the efﬁciency of
services is important as limited health
resources allocated to PR programmes mean
that not every patient with COPD who might
beneﬁt has access to them.17 It is important
therefore to be able to identify patients with
COPD who may need additional support to
complete a PR programme and also to iden-
tify those who may need additional input to
achieve a useful improvement.
Demographic factors, physiological mea-
surements and health-related quality of life
(HRQoL) questionnaires have been used to
investigate outcomes of interest in PR, such as
programme completion or impact on exercise
KEY MESSAGES
▸ In a real-life clinical setting of PR those COPD
patients most likely to benefit from PR appeared
the least likely to complete it.
▸ Improvement in different aspects following PR
was generally measure-specific so no single
baseline factor could predict a minimum clinical
important improvement in exercise capacity as
well as health status.
Boutou AK, Tanner RJ, Lord VM, et al. BMJ Open Resp Res 2014;1:e000051. doi:10.1136/bmjresp-2014-000051 1
Chronic obstructive pulmonary disease
capacity.2 3 6 To date, the optimum strategy for baseline
assessment in PR has not been deﬁned so published
studies and clinical programmes use a range of measures.
We conducted a multicentre study aiming to identify
whether there is an optimal tool or universal measure
that could independently predict: (1) the completion of
the PR programme and (2) achievement of the accepted
minimum clinically important difference (MCID) in
terms of exercise capacity and quality of life.
MATERIAL-METHODS
Population
We analysed data collected routinely from 787 patients
with COPD who attended at least the initial assessment
visit of an outpatient PR programme in one of eight
centres across London between March 2012 and March
2013. Diagnosis of COPD was based on postbronchodila-
tor forced expiratory volume in 1 s to forced vital cap-
acity ratio (FEV1/FVC) being <0.7. Patients were
included in the study when baseline anthropometric
characteristics, FEV1 and FEV1/FVC ratio had been
recorded, along with at least one outcome measure
(exercise capacity, dyspnoea score, or a HRQL question-
naire). Patients with a clinical diagnosis of asthma or
heart failure (New York Heart Association (NYHA)
III-IV) were excluded. The collation of data from the dif-
ferent programmes was approved by the Riverside
Research Ethics Committee.
All programmes followed British Thoracic Society (BTS)
guidelines regarding a combination of aerobic and
strength training. The programme included a mixture of
two supervised sessions and one or more unsupervised
home exercise sessions each week over 8–12 weeks.
Exercise prescription was based on the outcome of initial
exercise assessment and was increased through the pro-
gramme as tolerated. Programmes were multidisciplinary
with an educational component covering issues including
exercise (which was recommended during the programme
and was to continue after its completion), medication use,
diet and coping strategies, according to BTS
recommendations.
All patients underwent an initial evaluation before the
beginning of the programme and a second evaluation
immediately after PR completion. Patients with COPD
who completed at least 75% of the designated PR pro-
gramme and returned for the follow-up evaluation were
characterised as completers. Demographic characteristics
and pulmonary function testing variables were recorded
only once (before PR), while dyspnoea score, exercise
capacity measurements, anxiety and depression scale
scores and HRQL variables were recorded for COPD
completers prerehabilitation and postrehabilitation.
Measurements
Pulmonary function testing was completed according to
established guidelines. FEV1/FVC was recorded and
normal predicted values were calculated based on the
European Community for Steel and Coal reference
equations.18
Exercise capacity was evaluated using either the incre-
mental shuttle walk test (ISWT) or the 6 min walk test
(6MWT). Both exercise tests were conducted according
to the published literature.19 20 Dyspnoea was assessed in
a 5-point instrument during rest, using the Medical
Research Council (MRC) dyspnoea scale.21
The Hospital Anxiety and Depression (HAD) Scale
was utilised to assess the level of anxiety and depres-
sion.22 The HAD is a 14-item questionnaire consisting of
two seven-item subscales: one for assessing anxiety
(HAD-A) and one for assessing depression (HAD-D).
Subscales are rated between 0 and 21 and the higher
the scores, the higher the level of anxiety and depres-
sion, correspondingly. Scores of 0–7 in either HAD-A or
HAD-D subscale are considered normal, 8–10 borderline
and ≥11 clinical caseness.23
Quality of life was evaluated using the COPD assess-
ment test (CAT)24 or the Chronic Respiratory Disease
Questionnaire (CRDQ).25 The CAT consists of eight
items which are rated using a Likert-type scale of 0–5,
with higher scores representing worse quality of life. The
CRDQ consists of four domains: dyspnoea (ﬁve items)
(CRDQ-D), fatigue (four items) (CRDQ-F), emotional
function (seven items) (CRDQ-E) and mastery (four
items) (CRDQ-M); each domain is rated using a modi-
ﬁed 7-point Likert scale and higher scores represent
better quality of life. Subscores were obtained for each
domain and a total score for the whole CRDQ by adding
the four subscores, as previously described.26
Minimum clinical important difference
MCID was used to characterise which patients beneﬁted
from PR. This allowed comparison between programmes
using different outcome measures. The MCID for each
variable tested was deﬁned according to the published lit-
erature. An increase of more than 30 m and an increase of
more than 47.5 m was deﬁned as the MCID for the
6MWT27 and ISWT,28 correspondingly. The MCID for
MRC was deﬁned as a decrease of >1 in the dyspnoea
score,29 while for HAD-A and HAD-D questionnaires it was
deﬁned as an increase of >1.5.30 An increase of >0.5 was
used as the MCID for each of the CRDQ domains (dys-
pnoea, fatigue, emotional function and mastery).31 For
the CATa reduction of >2 points was deﬁned as MCID.11
Statistical analysis
Statistical analysis was performed using the Predictive
Analytics Software (PASW, SPSS Inc) V.18. Data are pre-
sented as mean±1 SD or as % percentages. Comparisons
before and after PR were conducted using paired-sample
t test. Independent samples t test and χ2 test were uti-
lised, as appropriate, for comparisons between com-
pleter and non-completer groups and between those
who established an MCID or not for all the outcomes of
interest. All parameters that were univariately associated
with either completion or MCID in each outcome were
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entered in a multivariate regression analysis model, to
allow independent predictors of PR completion and PR
effectiveness to be identiﬁed. OR with corresponding
95% CIs are reported for each independent predictor.
A level of p<0.05 was considered signiﬁcant.
RESULTS
The study population consisted of 787 outpatients with
COPD (68.1±10.5 years old; 49.6% males). Most patients
(42%) presented with Global Initiative for Obstructive
Lung Disease (GOLD) stage II (FEV1%predicted: 89.9%
±9.3%); 6.8% presented with GOLD stage I (FEV1%pre-
dicted: 62.4%±8.7%), 32.4% with GOLD stage III
(FEV1%predicted: 39.7%±5.6%) and 18.8% with GOLD
stage IV (FEV1%predicted: 23.4%±4.2%). In 30 patients
(3.8%) COPD was accompanied with bronchiectasis,
while one patient had α 1 antitrypsin deﬁciency.
Prior to entering PR, all 787 patients had completed
the MRC dyspnoea score and the CAT questionnaire.
Data on baseline exercise capacity were available for 664
patients (ISWT for N1=406 and 6MWT for N2=258).
Baseline anxiety and depression score was available for
640 patients, while 340 patients completed a second
HRQL questionnaire, which was CRDQ. No baseline dif-
ferences in demographic and clinical characteristics
were noted in the patient with COPD subgroup that
completed the extra-HRQL questionnaire. The baseline
demographic and clinical characteristics of the patient
population are presented in table 1.
Overall, 57.1% of patients (n=449) completed the PR
programme; reasons for not completing PR were not
systematically recorded. Patients who completed the PR
were older, had less severe disease (indicated by FEV1%
predicted), less anxiety and depression, (indicated by
the HAD-A and HAD-D questionnaires), less dyspnoea
prior to referral (indicated by the MRC score), and
better quality of life identiﬁed by lower scores in CAT,
and higher scores in CRDQ-E, CRDQ-M, CRDQ-F and
Total CRDQ (table 2). Baseline variables (FEV1/FVC
ratio, body mass index (BMI), CRDQ-D and exercise
capacity prior to referral) did not differ between the
groups.
Assessment at the end of the programme indicated
that PR had been beneﬁcial for participants as a group
(table 3), with signiﬁcant improvements in exercise cap-
acity, in terms of either 6MWT (p<0.001) or ISWT
(p<0.001) distance. Anxiety and depression scores fell
(both p<0.001) post PR. Quality of life also improved
with signiﬁcant fall in CAT score (p<0.001) while CRDQ
(total CRDQ, CRDQ-D, CRDQ-E, CRDQ-M and
CRDQ-F) increased (p<0.027; p<0.001; p<0.001; p<0.001
and p<0.001, correspondingly). MRC dyspnoea score
was also signiﬁcantly less (p<0.001).
Predictors of completion
All parameters univariately associated with PR comple-
tion were entered in a stepwise multivariate logistic
regression analysis model. In order to avoid
Table 1 Characteristics of the study population
Age (years) 68.1±10.5
Sex, male (%) 49.6
BMI (kg/m2) 26.9±6.5
FEV1 (%predicted) 49.7±19.7
FEV1/FVC 46.1±13.9
Pre-ISWT (m) 256±148
Pre-6MWT (m) 238±104.4
PR completion (%) 57.1
Pre-CAT 21±8
Pre-CRDQ_Total 14.4±4.6
Pre-CRDQ_D 2.8±1.3
Pre-CRDQ_E 4.1±1.5
Pre-CRDQ_F 3.5±2
Pre-CRDQ_M 4.3±1.7
Pre-HAD-A 7.9±4.8
Pre-HAD-D 7±4
Pre-MRC 3.3±0.9
6MWT, 6 min walking test; BMI, Body Mass Index; CRDQ,
Chronic Respiratory Disease Questionnaire; CRDQ_D, CRDQ
Dyspnoea domain; CRDQ_E, CRDQ Emotional function domain;
CRDQ_F, CRDQ Fatigue domain; CRDQ_M, CRDQ Mastery
domain; FEV1, Forced Expiratory Volume in 1 s; FVC, Forced Vital
Capacity; HAD, Hospital Anxiety (A) and Depression (D) Scale;
ISWT, Incremental Shuttle Walking Test; MRC, Medical Research
Council Dyspnoea Scale; PR, Pulmonary rehabilitation.
Table 2 Univariate differences between completers and
non-completers
Characteristics Completers
Non-
completers p Value
Age (years) 68.9±10.2 67±10.9 0.013
Sex (%)
Male 56.7 43.3 0.894
Female 57.4 42.6
BMI (kg/m2) 27.1±6.4 26.6±6.7 0.331
FEV1 (%predicted) 51.9±20.7 46.6±17.8 0.006
FEV1/FVC 46.6±13.8 45.6±13.9 0.740
Pre-ISWT (m) 264.9±148 249.2±147 0.164
Pre-6MWT (m) 246.8±99 229.2±109.1 0.175
Pre-CAT 20±7.8 22.3±8.2 <0.001
Pre-CRDQ_Total 15.2±4.4 13.2±4.5 <0.001
Pre-CRDQ_D 2.9±1.3 2.7±1.2 0.165
Pre-CRDQ_E 4.3±1.4 3.7±1.5 <0.001
Pre-CRDQ_F 3.8±2.1 3±1.3 <0.001
Pre-CRDQ_M 4.6±1.7 3.8±1.4 <0.001
Pre-HAD-A 7.1±4.6 8.9±4.8 <0.001
Pre-HAD-D 6.4±4 7.8±4.2 <0.001
Pre-MRC 3.2±0.9 3.4±0.9 0.001
Italics indicate significant p values (<0.05).
6MWT, 6 min walking test; BMI, Body Mass Index; CRDQ,
Chronic Respiratory Disease Questionnaire; CRDQ_D, CRDQ
Dyspnoea domain; CRDQ_E, CRDQ Emotional function domain;
CRDQ_F, CRDQ Fatigue domain; CRDQ_M, CRDQ Mastery
domain; FEV1, Forced Expiratory Volume in 1 s; FVC, Forced Vital
Capacity; HAD, Hospital Anxiety (A) and Depression (D) Scale;
ISWT, Incremental Shuttle Walking Test; MRC, Medical Research
Council Dyspnoea Scale; PR, Pulmonary rehabilitation.
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multicolinearity issues, only the total score of CRDQ
entered the analysis, since its individual domains were
very highly correlated to the total score (Pearson
r>0.85). Variables entered were: age, FEV1%predicted,
baseline CRDQ total, CAT, HAD-A, HAD-D and MRC
scores. The only independent predictor of PR comple-
tion was baseline CAT score (OR=0.925; 95% CI 0.879 to
0.974; p=0.003); the higher the baseline CAT score, the
lower the probability of completing the PR programme.
Predictors of achieving the MCID in exercise capacity
Among COPD completers, 68.3% (45.1% male; 67.7
±9.7 years old; 54.4±20.3 FEV1 %predicted) improved
exercise capacity by greater than the published MCID
after PR (group A), compared to patients who did not
establish this improvement (group B). Group A had
worse exercise capacity prior to PR, according to either
6MWT (236.1±92.4 m vs 284±80.9 m, p=0.014) or ISWT
(254.5±137.7 m vs 315.5±174.8 m, p=0.022) and this was
the only predictor of exercise MCID. Age, sex, lung
function, BMI, baseline CRDQ, SGRQ, CAT and MRC
dyspnoea score were not discriminatory in terms of
MCID in exercise capacity.
Predictors of MCID in HRQoL
PR had a signiﬁcant impact on CAT, CRDQ, HAD-A and
HAD-D scores. Since there is a variety of different
HRQoL questionnaires in use in clinical practice, MCID
predictors of HRQoL were investigated individually.
CAT
53.2% of completers achieved the MCID for the CAT
score. These patients were younger (66.7±9.7 vs 71.5
±9.9, p<0.001) and had lower CAT scores, that is, better
health status at baseline (22.5±7.5 vs 16.7±7.2, p<0.001).
Both these variables remained strong independent pre-
dictors of MCID in HRQoL after entering a stepwise
multivariate regression analysis model (OR for
age=0.960; 95% CI 0.938 to 0.983 and OR for CAT
pre-PR=1.101; 95% CI 1.068 to 1.135).
CRDQ
Predictors of MCID were identiﬁed for each of the four
domains individually. 56.2% of completers achieved the
MCID in CRDQ-D domain. These patients had a higher
FEV1/FVC ratio (51.1±12.9 vs 41.3±12, p=0.026), a worse
CRDQ-D baseline score (2.6±0.9 vs 3.3±1.6, p<0.001)
and were predominately female (67% vs 45.9%,
p=0.003). However, none of these variables remained an
independent predictor in the multivariate analysis; nor
did age, BMI, FEV1 %predicted, exercise capacity and
MRC score differ between the groups.
For CRDQ-E domain, MCID was achieved in 42.8% of
completers. These patients had higher baseline MRC
score (3.4±0.7 vs 2.9±0.8, p<0.001) and lower baseline
CRDQ-E score (3.7±1.2 vs 4.8±1.4, p<0.001). When
entered in a stepwise regression analysis model, baseline
MRC (OR=1.682, 95% CI 1.076 to 2.631; p=0.023) as
well as baseline CRDQ-E (OR=0.610, 95% CI 0.476 to
0.783; p<0.001) could predict MCID in CRDQ-E.
MCID for CRDQ-F domain was achieved in 58.6% of
patients with COPD who completed the PR programme.
These were younger (66.2±10.4 vs 70.7±10.8 years old,
p=0.003), had a higher MRC dyspnoea score (3.25±0.8
vs 2.9±0.8) and a lower baseline CRDQ-F score (3±1.1 vs
4.3±1.4, p<0.001) compared to the rest. In the multivari-
ate analysis, only age (OR=0.967; 95% CI 0.937 to 0.998,
p=0.039) and baseline CRDQ-F (OR=0.457; 95% CI
0.347 to 0.603, p<0.001) remained independent predic-
tors of achieving the CRDQ-F MCID.
Finally, 37.6% of completers achieved the MCID in
the CRDQ-M domain. These patients had higher MRC
dyspnoea score (3.4±0.7 vs 3±0.8, p=0.002) compared to
the rest of the completers. No other demographic or
clinical characteristic was found to be different between
these two groups.
Predictors of MCID in HAD scores
Among COPD completers, 31.7% achieved an improve-
ment above MCID in HAD-A. They had higher baseline
MRC dyspnoea score (3.3±0.9 vs 3.1±0.9, p=0.004) and
greater baseline anxiety (9.5±4.4 vs 5.8±4.1, p<0.001).
Age, sex, BMI, severity of obstruction and exercise cap-
acity were not associated with HAD-A improvement. In
the stepwise multivariate regression analysis, only base-
line HAD-A (OR=1.221; 95% CI 1.151 to 1.294, p<0.001)
could independently predict the presence of MCID in
HAD-A. Alternatively, HAD-A score was analysed based
on symptom severity subscale. Prior to PR, 51.6% of
patients were considered normal, 20.9% were consid-
ered borderline and the remaining 27.5% were potential
clinical cases. After PR completion, 64.5% of patients
were normal, 20.8% were borderline and only 14.7%
Table 3 Comparisons between pre and post pulmonary
rehabilitation among completers
Characteristics Pre PR Post PR p Value
ISWT (m) 264.9±148 350.1±158.7 <0.001
6MWT (m) 246.8±99 316±94.8 <0.001
CAT 20±7.8 17.8±7.5 <0.001
CDRQ_Total 15.2±4.4 15.8±4.7 0.027
CDRQ_D 2.9±1.3 3.6±1.4 <0.001
CDRQ_E 4.3±1.4 4.8±1.3 <0.001
CDRQ_F 3.8±2.1 4.1±1.3 <0.001
CDRQ_M 4.6±1.7 3.2±2.4 <0.001
HAD-A 7.1±4.6 6.3±4.2 <0.001
HAD-D 6.4±4 5.3±3.9 <0.001
MRC 3.2±0.9 2.6±0.9 <0.001
Italics indicate significant p values (<0.05).
6MWT, 6 min walking test; CRDQ, Chronic Respiratory Disease
Questionnaire; CRDQ_D, CRDQ Dyspnoea domain; CRDQ_E,
CRDQ Emotional function domain; CRDQ_F, CRDQ Fatigue
domain; CRDQ_M, CRDQ Mastery domain; HAD, Hospital
Anxiety (A) and Depression (D) Scale; ISWT, Incremental Shuttle
Walking Test; MRC, Medical Research Council Dyspnoea Scale;
PR, Pulmonary rehabilitation.
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were potential cases, and this difference was signiﬁcant
(p<0.001).
Improvement above HAD-D MCID threshold was
noted in 37.2% of completers. Similar to the HAD-A
results, patients were more breathless, according to MRC
dyspnoea score (3.3±0.8 vs 3±0.9, p<0.001) and had
worse baseline depression (8.3±3.7 vs 5.1±3.6, p<0.001),
compared to the rest of completers. Age, sex, BMI,
FEV1%predicted, FEV1/FVC ratio and exercise capacity
prior to PR were similar between the two groups.
Baseline HAD-D score was the only multivariate pre-
dictor of HAD-D MCID (OR=1.265; 95% CI 1.179 to
1.358, p<0.001). An analysis based on HAD-D symptom
severity subscale was also conducted. Prior to PR 61.1%
of patients were normal, 21.3% were borderline and the
remaining 17.6% were potential cases. The correspond-
ing percentages after PR completion were 74.5%, 16.9%
and 8.6% and the differences were statistically signiﬁcant
(p<0.001).
DISCUSSION
This is a multicentre study in a large population of
patients with COPD attending baseline assessment for
PR, which aimed to identify whether baseline factors
could predict completion of the programme and which
patients would achieve the MCID for exercise and
HRQoL in a clinical context. Participants who com-
pleted PR had less severe disease with HRQoL the only
independent predictor, but it was those with the most
severe disease who derived the greatest beneﬁt.
Improvement in different aspects following PR was gen-
erally measure-speciﬁc so no single baseline factor could
predict improvement in exercise capacity as well as
health status.
PR completion
The study identiﬁes a paradox: those most likely to beneﬁt
from PR appear least likely to complete it. Approximately
57% of patients with COPD completed the programme
consistent with previous UK data.13 Others have reported
much higher rates of PR completion ranging from more
than 80%2 to approximately 70%.32 33 Clinical practice
differs from the controlled environment of clinical trials
where patients have made a commitment to participation
by signing a consent form, have fewer comorbidities and
are usually under closer follow-up. Moreover, the deﬁn-
ition of PR completion varies; in the current study comple-
ters attended at least 75% of sessions and returned for a
follow-up visit, while other authors have used much lower
thresholds to deﬁne PR completion,2 13 32 so results are
not easily comparable.
The speciﬁc reasons for not completing PR were not
systematically collected and, thus, could not be further
analysed in the current study. Keating et al reported that
being unwell, having major difﬁculties travelling to the
PR centre, inconvenient running hours of the pro-
gramme, family issues, work responsibilities, lack of
social support and lack of perceived beneﬁt were the
most common reasons of dropping out from a PR pro-
gramme in a small group of 18 patients with COPD.34
Identifying the barriers of PR attendance and comple-
tion in real-life PR settings is an area of further research,
as resolving them could give the essential input for
patients to complete the PR programme.
CAT score was the only independent predictor of PR
completion, with completers having lower baseline CAT
scores, indicating a better health status. The COPD assess-
ment tool is a recently introduced questionnaire that
responds to PR in COPD as well as non-COPD popula-
tions11 35 and takes less time to complete than other
HRQoL questionnaires.36 The present data add to evi-
dence of its utility as an assessment measure in PR.11 12
To the authors’ knowledge, this is the ﬁrst time that CAT
has been identiﬁed as an independent predictor of PR
completion and this result needs to be further conﬁrmed
in large, prospective studies in the future.
Interestingly, HAD scores were not independent pre-
dictors of PR completion. In a cohort of 51 patients,
Garrod et al33 have previously shown that depressed
patients were in a signiﬁcantly higher risk of drop-out
compared to non-depressed patients. However, that study
utilised the Brief Assessment Schedule Depression Cards
and not the HAD-D score, in order to assess depression.
In another cohort of 111 COPD outpatients enrolled in a
community based programme, better mood independ-
ently predicted PR completion among female partici-
pants. In this study depression was assessed utilising
another tool, the Epidemiologic Studies Depression
Scale (CED-D).37 Several reliable, adult, self-report mea-
sures of depression, such as the PHQ-9, the Beck
Depression Inventory (BDI), the Geriatric Depression
Scale (GDS) and the CED-D,38 39 have been developed
and used in research and in clinical practice, making the
decision for the optimal measure to screen depression
among patients with COPD rather difﬁcult. Given the
fact that the presence of depression is associated with
poor adherence to treatment in COPD as well as in other
chronic conditions,40 41 more studies are needed in
order to identify the best tool when it comes to evaluating
the impact of depression on PR completion.
PR outcome measures
There is a huge body of evidence demonstrating PR pro-
grammes that include supervised exercise training
improve functional status, reduce symptom severity and
improve HRQoL among patients with COPD 3 4 7 and,
as expected, these effects were seen in the present study.
Since the programmes studied used a variety of tools for
evaluation (all employed the CAT score and the vast
majority of them the HADs) we used achievement of the
accepted MCID as an outcome measure to allow exercise
and HRQoL effects to be combined. A previous evalu-
ation of PR programmes suggested that although the
response to rehabilitation was good on average, some
patients achieved little or no beneﬁt.16 A further UK
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study indicated that almost 30% of patients who entered
a PR programme did not respond in terms of exercise
capacity or health status, even though the mean impact
of PR was beneﬁcial.42
No single parameter was found to predict achievement
of MCID for exercise and HRQoL. Poor exercise cap-
acity prior to PR was the only independent predictor of
clinically signiﬁcant improvement in exercise capacity
following completion of the programme. Some previous
studies have failed to establish a signiﬁcant association
between baseline physical condition, lung function para-
meters and exercise MCID,2 33 43 which may have been
due to insufﬁcient sample size. Troosters et al16 reported
that patients with reduced exercise capacity and reduced
respiratory and peripheral muscle strength were more
likely to improve after attendance at PR.
For the various HRQoL measures the achievement of
the MCID was best predicted by a worse baseline value
(CAT score, CRDQ-D, E, F). A higher MRC dyspnoea
score at baseline also predicted improvement in CRDQ
emotional function and fatigue domains and was the only
predictor of improvement in CRDQ-M. In a previous
study, Selzler et al2 failed to identify any predictor of
improvement in HRQoL; however, this study utilised the
SF-36 and the SGRQ. In another study, Garrod et al33 iden-
tiﬁed a higher baseline 6MWT as the only predictor of
improvement in HRQoL, assessed by the use of SGRQ. No
baseline physiological measurement has yet been shown to
predict signiﬁcant improvements in HRQoL.16 43
The greatest improvements in anxiety and depression
were in those with the highest scores at baseline, which is
understandable, as PR would not be expected to relieve a
condition that was not present. PR is partly effective as a
behavioural therapy, with graded exposure to dyspnoea
and learning coping strategies similar to the sort of
approaches applied in cognitive behavioural therapy.
METHODOLOGICAL ISSUES
The use of different outcome measures across the par-
ticipating study sites is a limitation of the current study;
however, it reﬂects the variability of baseline clinical
assessment in real life PR settings. Moreover, PR out-
comes were evaluated based on the MCID, an approach
which minimises the variability of measures applied. A
strength of the study is that it reﬂects clinical practice
with a less selected population than is generally
recruited to clinical trials and thus has greater relevance.
Data were entered prospectively onto a clinical database
and then anonymised by local staff before being collated
centrally, meaning that source veriﬁcation was not pos-
sible. It is unlikely that this would have introduced any
systematic bias. The clinical data available were limited
being based on those collected routinely as part of the
various PR programmes, so other factors such as motiv-
ation, sociodemographic status and reasons for drop-out
could not be considered. Moreover, some missing data
on baseline evaluation of exercise capacity and/or
HRQL reduce somewhat the study sample size; however,
this is a random phenomenon, unlikely to have pro-
duced any systematic bias.
CONCLUSION
The present study suggests that those with the worst
health status may need additional support to continue to
attend and complete PR programmes with possible strat-
egies including support for transport and lay-support.
Non-completion is an event rather than a permanent
state and health practitioners should review reasons for
non-completion with patients, reinforce the beneﬁts, and
encourage further participation as appropriate.
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